Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents.
Optical Coherence Tomography (OCT) Imaging
OCT images are obtained with the M2 OCT imaging system (LightLab Imaging, Inc., Westford, MA, USA). ImageWire is an imaging probe to deliver the light to the tissue and collect the signals. The ImageWire consists of 0.006"(0.15 mm) fiber-optic core, inside a sheath with a maximum O.D. of 0.019" (0.48 mm).
1. Anesthetize rat with isoflurane (2%) and ketamine (25 mg/kg). Under microscopic view, perform a median redo laparotomy to expose the infrarenal aorta. 2. Clamp the proximal aorta and both iliac artery. 3. Perform a transverse arteriotomy at the distal end of the aorta, flush with 1ml PBS using a 28G catheter and insert the OCT catheter and forward it into the aorta. 4. Motorized pullback OCT imaging is performed at a pullback rate of 1.0 mm per second. 5. Acquire images at 15 frames per second; images are displayed with a color look-up table and digitally archived. 6. Close the arteriotomy. 7. Close the abdominal and incisions with 4-0 Vicryl running sutures (Ethicon, Norderstedt, Germany).
The skin sutures should still be removed within 7-14 days even when Viacryl is used. 8. The maximum neointima formation will develop within 6 weeks after stent implantation.
Analyzing OCT images
OCT measurements are performed using the LightLab OCT imaging proprietary software with a rat-based interface.
1. Calibrate the system to the reflection of the OCT imaging wire, which is the standard calibration technique for this system. 2. Trace lumen and stent cross sectional areas (CSA) manually at each 1.0 mm intervals. 3. Calculate plaque cross sectional area as stent CSA subtracted from the lumen CSA. Calculate percent plaque area as plaque CSA divided by stent CSA (%). Calculate average percent plaque areas.
Validation of the OCT technique
OCT results correlate well with histopathology ( Figure 1 ). Histologic plaque CSAs are calculated as described above. Histology reveals intimal hyperplasia with high density of spindle-shaped cells and only few mononuclear inflammation cells. After 6 weeks, stents are completely covered with neointimal granulation tissue and the plaque CSA measures 1.3±0.4 mm 2 in a 2.5mm stent. . The rat stenting model is a simple, inexpensive, rapid, and accurate preclinical model 4 . After the initial report of direct stenting of the rat aorta by Lowe et al. 5 , feasibility and suitability of this model for the evaluation of the pathophysiology of in-stent restenosis has been thoroughly shown 5, 6 . The diameter of the rat aorta is adequate to allow expansion of commercially available stents without disruption of the physiologic vessel architecture. It has been shown that pathophysiological mechanisms, such as thrombus formation, inflammation, and SMC proliferation, develop in these rat models as they do in the rabbit and pig. Therefore, these models are good representations of the actual process of restenosis.
The OCT high-resolution imaging technology is useful to evaluate intimal hyperplasia. The penetration depth is only 1.5-2 mm, but its resolution is an order of magnitude greater than that of intravascular ultrasound (IVUS) 7, 8 . Multiple studies comparing OCT with IVUS conclude that OCT is currently the preferred technique to evaluate neointimal hyperplasia after stent implantation [8] [9] [10] . Especially in small animals with small vessel diameters, the high resolution of OCT renders it the best imaging modality for the evaluation of restenosis.
In summary, this video shows that (1) rat aortic stenting is easily feasible, (2) rat abdominal aorta stenting is suitable for testing commercially manufactured stents and (3) OCT imaging is an accurate and elegant technique for longitudinal monitoring of in-stent restenosis.
Disclosures
All rats were housed in the animal care facility at Stanford University Medical Center (Stanford, Ca), under standard temperature, humidity, and lighting conditions, and were provided rat chow and water ad libitum. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996). The study protocol was approved by the Administrative Panel on Laboratory Animal Care, Stanford University.
